Octapharma USA, Inc. Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care

Published: Jul 23, 2009

LACHEN, Switzerland and HOBOKEN, N.J., July 23 /PRNewswire/ -- Octapharma USA is now accepting applications for the Octapharma 25th Anniversary Grants Program, which supports clinical or pre-clinical research focused on human protein therapies in coagulation disorders, immunotherapy, intensive care and emergency medicine. Applications will be reviewed in October.

Back to news